ReviewChemical biology & drug design2026
Recent Advances in Conjugation Chemistry Expanding the Applications of the DNA Tetrahedron.
Review in Chemical biology & drug design, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
The tetrahedral DNA nanostructure (TDN) has emerged as a premier, highly programmable framework for targeted drug delivery and diagnostics. This review provides a definitive, chemistry-first design guide for TDN engineering, systematically structured across three translational tiers. First, we examine foundational derivatives, detailing how precise modifications across the three components of the nucleotide scaffold confer essential nuclease resistance and structural longevity. Second, a diverse array of conjugation strategies is compiled, mapping the chemical mechanics of stable and responsive covalent linkages alongside distinct non-covalent loading modalities, including intercalation, metallo-coordination, and groove binding. Third, we explore advanced derivatives for materials science, detailing how merging TDNs with traditional nanotechnology or smart polymeric matrices yields hybrid architectures engineered into sophisticated analytical tools and biomaterials. Advancing this platform will entail integration of AI-driven computational models and navigating critical physiological barriers, establishing the functionalized TDN as a definitive cornerstone of next-generation nanomedicine.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.